Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic Review

Stuart A. Kinner, Kathryn Snow, Andrea Wirtz, Frederick L. Altice, Christopher Beyrer, Kate Dolan

Research output: Contribution to journalReview article

Abstract

Purpose: This study aims to compare the global prevalence of hepatitis B, hepatitis C, HIV, and tuberculosis in incarcerated adolescents and young adults (AYAs) and older prisoners. Methods: This study is a systematic review and meta-analysis of studies reporting the age-specific prevalence of each infection in prisoners. We grouped age-specific prevalence estimates into three overlapping age categories: AYA prisoners (<25 years), older prisoners (≥25 years), and mixed category (spanning age 25 years). We used random effects meta-analysis to estimate the relative risk (RR) of each infection in AYAs versus older prisoners. Results: Among 72 studies, there was marked heterogeneity in prevalence estimates among AYA prisoners for all infections: hepatitis B (.4%–25.2%), hepatitis C (.0%–70.6%), HIV (.0%–15.8%), and active tuberculosis (.0%–3.7%). The pooled prevalence of HIV (RR =.39, 95% confidence interval.29–.53, I2 = 79.2%) and hepatitis C (RR =.51, 95% confidence interval.33–.78, I2 = 97.8%) was lower in AYAs than in older prisoners. Conclusions: The prevalence of HIV and hepatitis C is lower in AYA prisoners than in older prisoners. Despite lower prevalence, acquisition begins early among incarcerated populations. There is an urgent need for targeted, age-appropriate prevention, treatment, and harm reduction measures in and beyond custodial settings to reduce the incidence of infection in these extremely vulnerable young people.

Original languageEnglish (US)
Pages (from-to)S72-S80
JournalJournal of Adolescent Health
Volume62
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

Prisoners
Hepatitis C
Hepatitis B
Tuberculosis
HIV
Young Adult
Infection
Meta-Analysis
Harm Reduction
Age Factors
Incidence

Keywords

  • Adolescent
  • Hepatitis B
  • Hepatitis C
  • HIV
  • Injecting drug use
  • Meta-analysis
  • Prisoners
  • Tuberculosis
  • Young adult

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Public Health, Environmental and Occupational Health
  • Psychiatry and Mental health

Cite this

Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People : A Systematic Review. / Kinner, Stuart A.; Snow, Kathryn; Wirtz, Andrea; Altice, Frederick L.; Beyrer, Christopher; Dolan, Kate.

In: Journal of Adolescent Health, Vol. 62, No. 3, 01.03.2018, p. S72-S80.

Research output: Contribution to journalReview article

@article{b20cb21b3a6d4ffbb9d0a87e93df7ec1,
title = "Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic Review",
abstract = "Purpose: This study aims to compare the global prevalence of hepatitis B, hepatitis C, HIV, and tuberculosis in incarcerated adolescents and young adults (AYAs) and older prisoners. Methods: This study is a systematic review and meta-analysis of studies reporting the age-specific prevalence of each infection in prisoners. We grouped age-specific prevalence estimates into three overlapping age categories: AYA prisoners (<25 years), older prisoners (≥25 years), and mixed category (spanning age 25 years). We used random effects meta-analysis to estimate the relative risk (RR) of each infection in AYAs versus older prisoners. Results: Among 72 studies, there was marked heterogeneity in prevalence estimates among AYA prisoners for all infections: hepatitis B (.4{\%}–25.2{\%}), hepatitis C (.0{\%}–70.6{\%}), HIV (.0{\%}–15.8{\%}), and active tuberculosis (.0{\%}–3.7{\%}). The pooled prevalence of HIV (RR =.39, 95{\%} confidence interval.29–.53, I2 = 79.2{\%}) and hepatitis C (RR =.51, 95{\%} confidence interval.33–.78, I2 = 97.8{\%}) was lower in AYAs than in older prisoners. Conclusions: The prevalence of HIV and hepatitis C is lower in AYA prisoners than in older prisoners. Despite lower prevalence, acquisition begins early among incarcerated populations. There is an urgent need for targeted, age-appropriate prevention, treatment, and harm reduction measures in and beyond custodial settings to reduce the incidence of infection in these extremely vulnerable young people.",
keywords = "Adolescent, Hepatitis B, Hepatitis C, HIV, Injecting drug use, Meta-analysis, Prisoners, Tuberculosis, Young adult",
author = "Kinner, {Stuart A.} and Kathryn Snow and Andrea Wirtz and Altice, {Frederick L.} and Christopher Beyrer and Kate Dolan",
year = "2018",
month = "3",
day = "1",
doi = "10.1016/j.jadohealth.2017.09.030",
language = "English (US)",
volume = "62",
pages = "S72--S80",
journal = "Journal of Adolescent Health",
issn = "1054-139X",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People

T2 - A Systematic Review

AU - Kinner, Stuart A.

AU - Snow, Kathryn

AU - Wirtz, Andrea

AU - Altice, Frederick L.

AU - Beyrer, Christopher

AU - Dolan, Kate

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Purpose: This study aims to compare the global prevalence of hepatitis B, hepatitis C, HIV, and tuberculosis in incarcerated adolescents and young adults (AYAs) and older prisoners. Methods: This study is a systematic review and meta-analysis of studies reporting the age-specific prevalence of each infection in prisoners. We grouped age-specific prevalence estimates into three overlapping age categories: AYA prisoners (<25 years), older prisoners (≥25 years), and mixed category (spanning age 25 years). We used random effects meta-analysis to estimate the relative risk (RR) of each infection in AYAs versus older prisoners. Results: Among 72 studies, there was marked heterogeneity in prevalence estimates among AYA prisoners for all infections: hepatitis B (.4%–25.2%), hepatitis C (.0%–70.6%), HIV (.0%–15.8%), and active tuberculosis (.0%–3.7%). The pooled prevalence of HIV (RR =.39, 95% confidence interval.29–.53, I2 = 79.2%) and hepatitis C (RR =.51, 95% confidence interval.33–.78, I2 = 97.8%) was lower in AYAs than in older prisoners. Conclusions: The prevalence of HIV and hepatitis C is lower in AYA prisoners than in older prisoners. Despite lower prevalence, acquisition begins early among incarcerated populations. There is an urgent need for targeted, age-appropriate prevention, treatment, and harm reduction measures in and beyond custodial settings to reduce the incidence of infection in these extremely vulnerable young people.

AB - Purpose: This study aims to compare the global prevalence of hepatitis B, hepatitis C, HIV, and tuberculosis in incarcerated adolescents and young adults (AYAs) and older prisoners. Methods: This study is a systematic review and meta-analysis of studies reporting the age-specific prevalence of each infection in prisoners. We grouped age-specific prevalence estimates into three overlapping age categories: AYA prisoners (<25 years), older prisoners (≥25 years), and mixed category (spanning age 25 years). We used random effects meta-analysis to estimate the relative risk (RR) of each infection in AYAs versus older prisoners. Results: Among 72 studies, there was marked heterogeneity in prevalence estimates among AYA prisoners for all infections: hepatitis B (.4%–25.2%), hepatitis C (.0%–70.6%), HIV (.0%–15.8%), and active tuberculosis (.0%–3.7%). The pooled prevalence of HIV (RR =.39, 95% confidence interval.29–.53, I2 = 79.2%) and hepatitis C (RR =.51, 95% confidence interval.33–.78, I2 = 97.8%) was lower in AYAs than in older prisoners. Conclusions: The prevalence of HIV and hepatitis C is lower in AYA prisoners than in older prisoners. Despite lower prevalence, acquisition begins early among incarcerated populations. There is an urgent need for targeted, age-appropriate prevention, treatment, and harm reduction measures in and beyond custodial settings to reduce the incidence of infection in these extremely vulnerable young people.

KW - Adolescent

KW - Hepatitis B

KW - Hepatitis C

KW - HIV

KW - Injecting drug use

KW - Meta-analysis

KW - Prisoners

KW - Tuberculosis

KW - Young adult

UR - http://www.scopus.com/inward/record.url?scp=85042077802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042077802&partnerID=8YFLogxK

U2 - 10.1016/j.jadohealth.2017.09.030

DO - 10.1016/j.jadohealth.2017.09.030

M3 - Review article

C2 - 29455713

AN - SCOPUS:85042077802

VL - 62

SP - S72-S80

JO - Journal of Adolescent Health

JF - Journal of Adolescent Health

SN - 1054-139X

IS - 3

ER -